Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,879 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study.
Pezzolo E, Narcisi A, Gargiulo L, Di Lernia V, Napolitano M, Patruno C, Ribero S, Ortoncelli M, Foti C, Romita P, Gurioli C, Schena D, Ferrucci SM, Barei F, Amoruso GF, Russo F, Naldi L. Pezzolo E, et al. Among authors: russo f. J Am Acad Dermatol. 2024 Nov;91(5):e147-e150. doi: 10.1016/j.jaad.2024.06.094. Epub 2024 Jul 23. J Am Acad Dermatol. 2024. PMID: 39047985 No abstract available.
Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis).
Damiani G, Calzavara-Pinton P, Stingeni L, Hansel K, Cusano F; “Skin Allergy” Group of SIDeMaST; “ADOI” (Associazione Dermatologi Ospedalieri Italiani); “SIDAPA” (Società Italiana di Dermatologia Allergologica, Professionale e Ambientale); Pigatto PDM. Damiani G, et al. Dermatol Ther. 2019 Nov;32(6):e13121. doi: 10.1111/dth.13121. Epub 2019 Nov 7. Dermatol Ther. 2019. PMID: 31625221
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Fargnoli MC, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence Study Group. Stingeni L, et al. Among authors: russo f. J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1292-1299. doi: 10.1111/jdv.18141. Epub 2022 Apr 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35412683 Free PMC article.
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Gurioli C, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Esposito M, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence study group. Stingeni L, et al. Among authors: russo f. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18. J Eur Acad Dermatol Venereol. 2023. PMID: 36225088 No abstract available.
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E. Russo F, et al. Clin Cosmet Investig Dermatol. 2023 Dec 12;16:3561-3574. doi: 10.2147/CCID.S416149. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38107670 Free PMC article.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
Avallone G, Cavallo F, Tancredi A, Maronese CA, Bertello M, Fraghì A, Conforti C, Calabrese G, Di Nicola MR, Oddenino GA, Gargiulo L, Gori N, Loi C, Romita P, Piras V, Bonzano L, Tolino E, Paolino G, Napolitano M, Patruno C, Nettis E, Ferreli C, Roccuzzo G, Marozio L, Silvio M, Russo F, Bettolini L, Gallo R, Mercuri SR, Mastorino L, Rossi M, Zalaudek I, Argenziano G, Trave I, Costanzo A, Chiricozzi A, Gurioli C, Foti C, Potenza C, Ferrucci SM, Balato A, Parodi A, Marzano AV, Ortoncelli M, Ribero S, Quaglino P. Avallone G, et al. Among authors: russo f. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1799-1808. doi: 10.1111/jdv.19794. Epub 2024 Jan 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38284131
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens.
Stingeni L, Bianchi L, Caroppo ES, Belloni Fortina A, Caroppo F, Corazza M, Borghi A, Gallo R, Trave I, Ferrucci SM, Beretta A, Guarneri F, Martina E, Napolitano M, DE Lucia M, Patruno C, Bennardo L, Romita P, Foti C, Tramontana M, Marietti R, Argenziano G, Hansel K; Skin Allergy group of SIDeMaST and Società Italiana di Dermatologia Allergologica, Professionale e Ambientale (SIDAPA). Stingeni L, et al. Ital J Dermatol Venerol. 2024 Apr;159(2):83-104. doi: 10.23736/S2784-8671.24.07733-8. Ital J Dermatol Venerol. 2024. PMID: 38650492 Free article.
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients.
Ferrucci S, Tavecchio S, Maronese CA, Balato A, Di Brizzi EV, Ortoncelli M, Ribero S, Girolomoni G, Maurelli M, Fortina AB, Caroppo F, Naldi L, Pezzolo E, Nettis E, Pugliese F, Stingeni L, Hansel K, Rubegni G, Calabrese L, Russo F, Gola M, Magnaterra E, Rongioletti F, Mercuri SR, Paolino G, Savoia P, Veronese F, Foti C, Ambrogio F, Scalvenzi M, Napolitano M, Patruno C, Dastoli S, Corazza M, Borghi A, Calzavara-Pinton PG, Rossi M, Offidani A, Radi G, Bonzano L, Ferreli C, Piras V, Satta R, Sucato F, Malagoli P, Gaiani F, Micali G, Musumeci ML, Fargnoli MC, Esposito M, Grieco T, Chello C, Casazza G, Marzano AV. Ferrucci S, et al. Among authors: russo f. Clin Exp Dermatol. 2024 Nov 22;49(12):1561-1572. doi: 10.1093/ced/llae208. Clin Exp Dermatol. 2024. PMID: 38860563
Impact of dupilumab discontinuation in a patient with atopic prurigo.
Milanesi N, Tronconi G, Gola M, Flori ML, Russo F. Milanesi N, et al. Among authors: russo f. Ital J Dermatol Venerol. 2021 Jun;156(3):406. doi: 10.23736/S2784-8671.20.06714-0. Epub 2020 Oct 21. Ital J Dermatol Venerol. 2021. PMID: 33084269 No abstract available.
1,879 results